Vaso corporation announces fourth extension of exclusive sales representation agreement with ge healthcare

Plainview, ny / accesswire / october 29, 2021 / vaso corporation ("vaso") (otcmkts:vaso) today announces the amendment of the sales representation agreement between its subsidiary, vaso diagnostics, inc. d/b/a vasohealthcare, and ge healthcare ("gehc"), the healthcare business unit of general electric company (nyse:ge), originally signed on may 19, 2010. the amendment extends the term of the original agreement, which began on july 1, 2010 and was previously extended in 2012, 2015 and 2017, through december 31, 2026, subject to earlier termination under certain circumstances, making it a contract of five years from the end of this year.
GE Ratings Summary
GE Quant Ranking